Core Viewpoint - Chewy Inc (NYSE:CHWY) is considered a strong e-commerce investment, with Piper Sandler maintaining an Overweight rating and setting a price target of $48.00, influenced by concerns regarding pet ownership and BC Partners' significant stake [1] Group 1: Earnings and Guidance - Chewy Inc's 2025 earnings are expected to align more closely with consensus expectations, showing only a 3% EBITDA beat year-to-date compared to a 22% average beat in 2024 [2] - The company is anticipated to adopt a conservative approach for 2026, guiding for 7-8% sales growth against the Street's expectation of 8% [2] - Chewy is likely to maintain a consensus EBITDA margin of 6.6%, with potential upside from improved leverage [2] Group 2: Market Sentiment and Price Targets - Morgan Stanley raised its price target for Chewy Inc to $51 from $48 while keeping an Overweight rating, suggesting a positive outlook for 2026 in the internet sector [3] - Goldman Sachs also sees long-term upside for Chewy, raising its target to $52 [7] Group 3: Company Overview - Chewy Inc operates as an online retailer specializing in pet food and related products, offering a range of services including Chewy Pharmacy and veterinary connections [4]

Core Viewpoint - Chewy, Inc. (NYSE:CHWY) is considered a stock under $50 with potential for investment, supported by varying price target adjustments from different analysts [1][2]. Analyst Ratings and Price Targets - Morgan Stanley raised the price target for Chewy, Inc. to $51 from $48, maintaining an 'Overweight' rating, indicating a positive outlook for the company in the internet sector [1]. - Wolfe Research lowered its price target for Chewy, Inc. to $44 from $46 while keeping an 'Outperform' rating, suggesting a cautious but still favorable view on the company's performance relative to the internet sector [2]. - A consensus of 69% of analysts recommend a 'Buy' rating for Chewy, Inc., with a median price target of $46, indicating an upside potential of 41.84% [3]. Company Overview - Chewy, Inc. is a Florida-based company that provides pet food, medications, and health products, as well as pet services, operating through retail websites and mobile applications [4].

Company Overview - PetMed Express, Inc. is an online pet pharmacy founded in 1996, offering a wide range of medications, supplements, food, and other pet health products [3] Allegations and Stock Performance - On June 10, 2025, PetMed announced a delay in releasing its fourth-quarter and full-year 2025 financial results, leading to a stock drop of $0.47, or 11.22%, closing at $3.72 on June 11, 2025 [4] - On July 1, 2025, PetMed stated it would not file its fiscal-year 2025 Annual Report on time due to an internal review of revenue recognition, resulting in a stock decline of $0.05 per share, or 1.51%, finishing at $3.27 [5] - On November 12, 2025, PetMed reported it could not timely submit its third-quarter 2025 Form 10-Q due to an Audit Committee investigation, causing a significant stock price drop of $0.94 per share, or 32.41%, closing at $1.96 on November 13, 2025 [6] Legal Investigation - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving PetMed Express, stemming from allegations of providing misleading business information to the investing public [1]